Deptula-Hicks Darlene M
SEC-identified person · CIK 1089409 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aldeyra Therapeutics, Inc. ALDX | Director | filed 2026 - 2026 |
| Spring Bank Pharmaceuticals, Inc. SBPH | Treasurer and CFO | filed 2020 - 2023 |
| Xenetic Biosciences, Inc. XBIO | Director | filed 2016 - 2017 |
| T2 Biosystems, Inc. TTOO | SVP & Chief Financial Officer | filed 2017 - 2017 |
| Pieris Pharmaceuticals, INC. PVLA | Sr. Vice President and CFO | filed 2015 - 2016 |
| Icad INC icad07 | Executive VP of Finance, CFO | filed 2006 - 2011 |
| Technest Holdings INC TCNH.OB | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.